March 5, 2026 · Form 4 insider transaction
MAHON PAUL A sold 1,006 shares of United Therapeutics Corporation at $485.32 per share, a transaction worth $488.2K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.
This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025.; This transaction was executed in multiple trades at prices ranging from $485.10 to $485.61. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.